Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 15 October 2008, Vol. 112, No. 8, pp. 3099-3106.
Prepublished online as a Blood First Edition Paper on June 5, 2008; DOI 10.1182/blood-2008-01-133918.


This Article
Right arrow Full Text (PDF)
Right arrow Supplemental Appendices and Figure
Right arrow All Versions of this Article:
blood-2008-01-133918v1
112/8/3099    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Peffault de Latour, R.
Right arrow Articles by Socie, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Peffault de Latour, R.
Right arrow Articles by Socie, G.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Next Article next article arrow

Submitted January 16, 2008
Accepted May 14, 2008

Paroxysmal nocturnal hemoglobinuria: natural history of disease subcategories

R. Peffault de Latour, J. Y. Mary, C. Salanoubat, L. Terriou, G. Etienne, M. Mohty, S. Roth, S. de Guibert, S. Maury, J. Y. Cahn, and G. Socie*

Service d'Hematologie Greffe de Moelle, Hopital Saint Louis, Paris, France
Unite INSERM 717 – Universite Paris 7, DBIM, Hopital Saint Louis, Paris, France
Hematologie clinique, Hotel Dieu, Paris, France
Service des Maladies du Sang, Hopital Claude Huriez, Lille, France
Service de Medecine Interne, Groupe Hospitalier Sud, Pessac, France
Unite de Transplantation et de Therapie Cellulaire, Institut Paoli Calmettes, Marseille, France
Service de Medecine Interne, Hopital Archet, Nice, France
Service d'Hematologie Clinique, Centre hospitalier Pontchaillou, Rennes, France
Service d'Hematologie Clinique, Hopital Henri-Mondor, Paris, France
Service d'Onco-Hematologie, Hopital Michallon, Grenoble, France

* Corresponding author; email: gerard.socie{at}sls.aphp.fr.

The natural history of PNH clinical subcategories (Classic PNH and aplastic anemia (AA) /PNH syndrome) is still unknown. We retrospectively studied 460 PNH patients diagnosed in 58 French hematological centers from 1950 to 2005. The median (SE) follow-up time was 6.8 (0.5) years. The median survival time was 22 (2.5) years. We identified 113 patients with Classic PNH, 224 patients with AA-PNH syndrome, and 93 (22%) intermediate patients who did not fit within these 2 categories. At presentation, Classic PNH patients were older, with more frequent abdominal pain and displayed higher levels of GPI-AP-deficient granulocytes. A time-dependent improved survival was observed. In classic PNH, diagnoses before 1986 (Hazard Ratio (HR) 3.6; p=0.01) and increasing age (p<0.001) were associated with worse survival prognoses, while use of androgens within the first year after diagnosis was protective (HR 0.17; p=0.01). Transfusions before 1996 (HR 2.7; p=0.007) led to lower survival rates in patients with AA-PNH syndrome, while immunosuppressive treatment was associated with better outcomes (HR 0.33; p=0.03). Evolution to thrombosis affected survival in both subcategories (Classic PNH: HR 7.8, p<0.001; AA-PNH syndrome HR 33.0, p<0.001). Evolution to bi- or pancytopenia for Classic PNH (HR 7.3, p<0.001) and malignancies for AA-PNH syndrome (HR 48.8; p<0.001) were associated with worse outcomes. Although clinical presentation and prognosis factors are different, Classic PNH and AA-PNH syndrome present roughly similar outcomes, mainly affected by complications.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
BloodHome page
R. A. Brodsky
How I treat paroxysmal nocturnal hemoglobinuria
Blood, June 25, 2009; 113(26): 6522 - 6527.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
D. Dingli, L. Luzzatto, and J. M. Pacheco
Neutral evolution in paroxysmal nocturnal hemoglobinuria
PNAS, November 25, 2008; 105(47): 18496 - 18500.
[Abstract] [Full Text] [PDF]



 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2008 by American Society of Hematology         Online ISSN: 1528-0020